{
    "2019-08-14": [
        [
            {
                "time": "2018-11-15",
                "original_text": "Novartis Reportedly Fires Brothers For Manipulating Gene Therapy Data",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Fires",
                        "Manipulating",
                        "Gene",
                        "Therapy",
                        "Data"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-20",
                "original_text": "Wednesday’s Vital Data: Amgen, American Airlines and Apple",
                "features": {
                    "keywords": [
                        "Vital",
                        "Data",
                        "Amgen",
                        "American",
                        "Airlines",
                        "Apple"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "transportation",
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-10",
                "original_text": "Deciphera's GIST Drug Succeeds in Pivotal Study, Stock Up 80%",
                "features": {
                    "keywords": [
                        "Deciphera",
                        "GIST",
                        "Drug",
                        "Succeeds",
                        "Pivotal",
                        "Study",
                        "Stock",
                        "Up"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-12",
                "original_text": "Lilly's Taltz Outshines J&J's Tremfya in Psoriasis Study",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Taltz",
                        "Outshines",
                        "J&J",
                        "Tremfya",
                        "Psoriasis",
                        "Study"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-22",
                "original_text": "UPDATE 2-Novartis replaces top scientists at Avexis after drug data manipulated",
                "features": {
                    "keywords": [
                        "Novartis",
                        "replaces",
                        "top",
                        "scientists",
                        "Avexis",
                        "drug",
                        "data",
                        "manipulated"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-05-23",
                "original_text": "Everyone’s Mad At Novartis. But the Stock Is Doing Just Fine",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Mad",
                        "Stock",
                        "Fine"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-22",
                "original_text": "Novartis replaces top scientists at Avexis after drug data manipulated",
                "features": {
                    "keywords": [
                        "Novartis",
                        "replaces",
                        "top",
                        "scientists",
                        "Avexis",
                        "drug",
                        "data",
                        "manipulated"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-06-01",
                "original_text": "Novartis names Bulto as new head of U.S. drugs business",
                "features": {
                    "keywords": [
                        "Novartis",
                        "names",
                        "Bulto",
                        "head",
                        "U.S.",
                        "drugs",
                        "business"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-05-21",
                "original_text": "Novartis ousted scientists before reporting drug data manipulation",
                "features": {
                    "keywords": [
                        "Novartis",
                        "ousted",
                        "scientists",
                        "reporting",
                        "drug",
                        "data",
                        "manipulation"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}